Nature Microbiology Клеточная биология

Turning a Staphylococcus aureus virulence factor into an antibacterial therapy

Springer Nature · 2026-11-01 · DOI 10.1038/s41564-026-02512-2

Аннотация

We describe FibriLysins, dual-action proteins that dismantle the fibrin structures encapsulating Staphylococcus aureus multicellular communities and kill the bacteria within. In a mouse model of device-associated infection, FibriLysins demonstrate higher antibacterial efficacy compared with the standard-of-care antibiotic vancomycin. These findings highlight the potential of FibriLysins to treat recalcitrant S. aureus infections.

Читать у издателя →